Real-time Euronext Amsterdam 05:00:10 2024-06-25 EDT 5-day change 1st Jan Change
24.16 EUR -1.59% Intraday chart for Philips NV +0.25% +18.50%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading MT
Philips: cancellation of almost 4.4 million shares CF
Royal Philips Receives FDA 510(K) Clearance for Zenition 90 Motorized Mobile C-Arm MT
Royal Philips Zenition 90 Motorized Receives FDA 510(k) clearance, helping clinicians deliver high quality care with a high-powered and fast motorized mobile C-arm CI
Royal Philips Introduces Duo Venous Stent System for Symptomatic Venous Outflow Obstruction MT
Philips Launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction CI
PHILIPS NV : Goldman Sachs keeps its Buy rating ZD
Royal Philips Introduces AI-Powered Cardiovascular Ultrasound Platform MT
Philips: refinancing for 700 million euros CF
Royal Philips Prices EUR700 Million of Notes due 2032 MT
Philips Prices 700 Million Euros Fixed Rate Notes Offering MT
Royal Philips Launches Ambulatory Cardiac Monitoring Service in Spain MT
Royal Philips Rolls Out Ambulatory Cardiac Monitoring Tools in Spain MT
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading MT
Koninklijke Philips N.V. (Royal Philips) to Issue 30.86 Million New Shares After Setting Dividend Exchange Ratio for 2023 MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading MT
PHILIPS : Jefferies remains negative, but raises its target CF
Transcript : Koninklijke Philips N.V. - Shareholder/Analyst Call
PHILIPS NV : Jefferies remains a Sell rating ZD
Elekta to Buy Philips Healthcare's Treatment Planning Patent Portfolio MT
PHILIPS NV : DZ Bank reiterates its Neutral rating ZD
Moody's Affirms Royal Philips' Rating, Upgrades Outlook on Enhanced Performance MT
UBS Upgrades Koninklijke Philips to Neutral From Sell MT
PHILIPS : Deutsche Bank upgrades recommendation to 'hold CF
Chart Philips NV
More charts
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
24.55 EUR
Average target price
25.12 EUR
Spread / Average Target
+2.33%
Consensus
  1. Stock Market
  2. Equities
  3. PHIA Stock
  4. News Philips NV
  5. Royal Philips Prices EUR700 Million of Notes due 2032